Drug intelligence / Profile preview

Innopea

Development stage
Unknown
Lead developer
INNventa Pharm
Modality
Small Molecules
Administration
Oral
01

Overview

Innopea is a dietary supplement and food for special medical purposes (FSMP) developed by INNventa Pharm, specifically formulated for the management of chronic and neuropathic pain. The product contains a combination of palmitoylethanolamide (PEA) and B-complex vitamins, including thiamine (B1), pyridoxine (B6), and cyanocobalamin (B12). Palmitoylethanolamide is an endogenous fatty acid amide that acts as a peroxisome proliferator-activated receptor alpha (PPAR-α) agonist. By activating PPAR-α, PEA modulates neuroinflammation and pain signaling pathways, particularly by downregulating the activity of mast cells and microglia. The addition of B vitamins supports the metabolic health and regeneration of peripheral nerves. Innopea is marketed for conditions such as sciatica, carpal tunnel syndrome, and diabetic neuropathy.

Brand names
Innopea
Other names
palmitoylethanolamide + vitamin B1 + vitamin B6 + vitamin B12
02

Targets

PPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on Innopea.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innopea.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call